Financing strengthens balance sheet, extending expected runway into the second quarter of 2026 Enables accelerated ...

NanoPortal™ technology successfully delivers semaglutide, the active ingredient in Ozempic®/Wegovy®, in a preclinical study ...

GLP-1 receptor agonists, originally introduced in 2006, have undergone significant advancements over the years. David Ricks, ...

Just because a research project sounds like a waste of money to people who know nothing of the topic, doesn’t mean it won’t ...